Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag Jaguar Health reduced debt, extended credit, and advanced crofelemer development with non-dilutive funding efforts.

flag Jaguar Health has improved its financial health by restructuring debt and royalty obligations with Chicago Venture Partners affiliates, reducing $3 million in liabilities, extending a $7 million credit line by three years, and eliminating 48,212 warrants. flag No debt from these affiliates matures before July 2026, easing near-term pressure. flag The company continues advancing its crofelemer development program for rare gastrointestinal disorders, with sustainable harvesting managed by Napo Pharmaceuticals under fair trade practices. flag Jaguar is pursuing non-dilutive funding through potential partnerships and expects clinical milestones in its intestinal failure program. flag Forward-looking statements are subject to risks.

4 Articles